In re: Drogueria Betances, et al v. Pfizer Inc, et al
| PROFESSIONAL DRUG CO INC, ROCHESTER DRUG COOPERATIVE INC, DROGUERIA BETANCES, VALUE DRUG CO and STEPHEN L LAFRANCE HOLDINGS INC |
| RANBAXY INC, PFIZER IRELAND PHARMACEUTICALS, PFIZER INC, WARNER LAMBERT CO, RANBAXY PHARMACEUTICALS INC, WARNER LAMBERT CO LLC and RANBAXY LABORATORIES LTD |
| In re: LIPITOR ANTITRUST LITIGATION |
| 24-2203 |
| July 8, 2024 |
| U.S. Court of Appeals, Third Circuit |
| Antitrust |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 4, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 37 NOTICE Pursuant to 3d Cir. L.A.R. 26.1, a document is timely filed if received by 5:00 p.m. ET on the last day for filing unless the Court sets a different time, the document has been submitted by an inmate pursuant to Fed. R. App. P. 25(a)(2)(A)(iii), or otherwise specified in L.A.R. 26.1 [24-2184, 24-2185, 24-2189, 24-2194, 24-2202, 24-2203, 24-2256, 24-2257] (AMR) [Entered: 09/04/2024 12:55 PM] |
| Filing 36 BRIEFING NOTICE ISSUED. Brief on behalf of Appellants Meijer Distribution Inc, Meijer Inc, HEB Grocery Co LP, Safeway Inc, SuperValu Inc, The Kroger Co, Walgreen Co, Giant Eagle Inc, CVS Pharmacy Inc, Eckerd Corp, JCG (PJC) USA LLC, Maxi Drug Inc, Rite Aid Corp, Rite Aid Hdqtrs Corp, Drogueria Betances, Professional Drug Co Inc, Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc, Value Drug Co, AF of L AGC Building Trades Welfare Plan, Bakers Local 433 Health Fund, Nancy Billington, Fraternal Order of Police Fort Lauderdale Lodge 31 Insurance Trust Fund, Emilie Heinle, Andrew Livezey, Louisiana Health Service Indemnity Co, Mayor and City Council of Baltimore and New Mexico United Food and Commercial Workers Unions and Employers Health and Welfare Trust Fund due on or before 10/15/2024. Appendix due on or before 10/15/2024. [24-2185, 24-2184, 24-2189, 24-2194, 24-2202, 24-2203, 24-2256, 24-2257] (AMR) [Entered: 09/04/2024 12:48 PM] |
| Filing 35 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Warner Lambert Co LLC. [24-2256] (RAM) [Entered: 08/27/2024 05:17 PM] |
| Filing 34 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Pfizer Ireland Pharmaceuticals. [24-2256] (RAM) [Entered: 08/27/2024 05:13 PM] |
| Filing 33 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Pfizer Inc. [24-2256] (RSG) [Entered: 08/27/2024 03:22 PM] |
| Filing 32 ECF FILER: ENTRY OF APPEARANCE from Raj Gandesha on behalf of Appellee(s) Pfizer Inc.; Pfizer Ireland Pharmaceuticals; Warner-Lambert Co.; Warner-Lambert Company LLC. [24-2256] (RSG) [Entered: 08/27/2024 03:21 PM] |
| Filing 31 ECF FILER: ENTRY OF APPEARANCE from Robert Milne on behalf of Appellee(s) Pfizer Inc.; Pfizer Ireland Pharmaceuticals; Warner-Lambert Co.; Warner-Lambert Company LLC. [24-2256] (RAM) [Entered: 08/27/2024 03:12 PM] |
| Filing 30 FOLLOW UP LETTER to Dimitrios T. Drivas, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Jessica K. Formichella, Esq. for Appellees Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Michael J. Gallagher, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Liza M. Walsh, Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, William T. Walsh, Jr., Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC and Brendan G. Woodard, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC in 24-2184, 24-2185, Dimitrios T. Drivas, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Jessica K. Formichella, Esq. for Appellees Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Michael J. Gallagher, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Liza M. Walsh, Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, William T. Walsh, Jr., Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC and Brendan G. Woodard, Esq. for Appellee Warner Lambert Co LLC in 24-2189, Dimitrios T. Drivas, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Jessica K. Formichella, Esq. for Appellees Warner Lambert Co, Pfizer Ireland Pharmaceuticals, Ranbaxy Pharmaceuticals Inc and Warner Lambert Co LLC, Michael J. Gallagher, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Liza M. Walsh, Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, William T. Walsh, Jr., Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC and Brendan G. Woodard, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC in 24-2194, 24-2202, 24-2203, 24-2256 requesting the following document(s): Appearance Form within 14 days. Disclosure Statement on or before 08/27/2024. [24-2184, 24-2185, 24-2189, 24-2194, 24-2202, 24-2203, 24-2256] (AMR) [Entered: 08/13/2024 02:33 PM] |
| Filing 29 CLERK (ORDER) The Retailer Plaintiffs and Direct Purchaser Plaintiffs filed six appeals (Nos. 24-2184, 24-2185, 24-2189, 24-2194, 24-2202, & 24-2203) that were previously consolidated. Later, the End Payor Plaintiffs filed two appeals (Nos. 24-2256 & 24-2257), which were consolidated together for all purposes. They are now further consolidated with the Retailer Plaintiffs' and Direct Purchaser Plaintiffs' appeals so that all eight appeals are consolidated for purposes of scheduling, the joint appendix, the appellees' response brief, and disposition. The appellants are encouraged to consult with one another regarding the contents of their briefs as the Court disfavors repetitive briefs. The appellants may file a consolidated brief or join in or adopt portions by reference. See Fed. R. App. P. 28(i). The parties are hereby directed to electronically file documents on the Court's docket as follows: Appellants: All case opening forms, motions, and briefs must be filed only in the appeal number assigned to the filer's notice of appeal. If a document is being filed jointly by multiple appellants, the document must be filed in the appeal numbers assigned to the filing appellants. Appellees: All case opening forms must be filed in all appeals in which the appellee intends to participate. All motions should be filed only in those cases for which the relief is being requested. Appellee's consolidated brief must be filed in all appeals to which the appellee is responding. The consolidated joint appendix must be filed in all appeal numbers. The parties are advised that failure to file documents in the appropriate case may result in the issuance of a noncompliance order. If any party is unsure how to file a particular document, he or she should call the case manager prior to filing the document. [24-2184, 24-2185, 24-2189, 24-2194, 24-2202, 24-2203, 24-2256] (AMR) [Entered: 08/01/2024 12:23 PM] |
| Filing 28 FOLLOW UP LETTER to Dimitrios T. Drivas, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Jessica K. Formichella, Esq. for Appellees Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Michael J. Gallagher, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, Liza M. Walsh, Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC, William T. Walsh, Jr., Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC and Brendan G. Woodard, Esq. for Appellees Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC in 24-2184, Liza M. Walsh, Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC and William T. Walsh, Jr., Esq. for Appellees Pfizer Inc, Warner Lambert Co, Pfizer Ireland Pharmaceuticals and Warner Lambert Co LLC in 24-2185 requesting the following document(s): Appearance Form within 14 days. Disclosure Statement on or before 08/09/2024. [24-2184, 24-2185, 24-2189, 24-2194, 24-2202, 24-2203] (AMR) [Entered: 07/26/2024 04:22 PM] |
| Filing 27 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Ranbaxy Pharmaceuticals Inc. [24-2203] (DWA) [Entered: 07/22/2024 05:32 PM] |
| Filing 26 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Ranbaxy Laboratories Ltd. [24-2203] (DWA) [Entered: 07/22/2024 05:31 PM] |
| Filing 25 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Ranbaxy Inc. [24-2203] (DWA) [Entered: 07/22/2024 05:31 PM] |
| Filing 24 ECF FILER: ENTRY OF APPEARANCE from Gilad Bendheim on behalf of Appellee(s) Ranbaxy Inc., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories Ltd.. [24-2203] (GYB) [Entered: 07/22/2024 04:29 PM] |
| Filing 23 ECF FILER: ENTRY OF APPEARANCE from Alexandra I. Russell on behalf of Appellee(s) Ranbaxy Inc., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories Ltd.. [24-2203] (AIR) [Entered: 07/22/2024 04:18 PM] |
| Filing 22 ECF FILER: ENTRY OF APPEARANCE from Devora W. Allon on behalf of Appellee(s) Ranbaxy Inc., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories Ltd.. [24-2203] (DWA) [Entered: 07/22/2024 04:04 PM] |
| Filing 21 ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellants Drogueria Betances, Professional Drug Co Inc, Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc and Value Drug Co. [24-2203] (PSP) [Entered: 07/22/2024 03:44 PM] |
| Filing 20 ECF FILER: Concise Summary of the Case filed by Appellants Drogueria Betances, Professional Drug Co Inc, Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc and Value Drug Co. [24-2203] (PSP) [Entered: 07/22/2024 03:43 PM] |
| Filing 19 ECF FILER: ENTRY OF APPEARANCE from Jay P. Lefkowitz on behalf of Appellee(s) Ranbaxy Inc., Ranbaxy Pharmaceuticals, Inc., and Ranbaxy Laboratories Ltd.. [24-2203] (JPL) [Entered: 07/22/2024 03:38 PM] |
| Filing 18 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Stephen L LaFrance Holdings Inc in 24-2202, 24-2203. [24-2202, 24-2203] (GTA) [Entered: 07/22/2024 02:17 PM] |
| Filing 17 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Professional Drug Co Inc in 24-2202, 24-2203. [24-2202, 24-2203] (GTA) [Entered: 07/22/2024 02:12 PM] |
| Filing 16 ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellants Drogueria Betances, Professional Drug Co Inc, Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc and Value Drug Co advising this court that transcripts are already on file in the District Court. Requested date(s) are: Per the Court Reporter, Kimberly Wilson, the transcript is completed. A copy of the transcript has been provided to counsel. We requested the Court Reporter to place the transcript on the DNJ docket., to be filed by Kimberly Wilson. [24-2203] (PSP) [Entered: 07/19/2024 02:54 PM] |
| Filing 15 ECF FILER: ENTRY OF APPEARANCE from Gregory T. Arnold on behalf of Appellant(s) Stephen L. LaFrance Holdings, Inc. and Professional Drug Company, Inc.. [24-2203] (GTA) [Entered: 07/19/2024 01:16 PM] |
| Filing 14 ECF FILER: ENTRY OF APPEARANCE from Thomas M. Sobol on behalf of Appellant(s) Stephen L. LaFrance Holdings, Inc. and Professional Drug Company, Inc.. [24-2203] (TMS) [Entered: 07/19/2024 01:09 PM] |
| Filing 13 ECF FILER: DISCLOSURE STATEMENT on behalf of Drogueria Betances, LLC, Rochester Drug Co-Operative, Inc. and Value Drug Co.. [24-2203] (PSP) [Entered: 07/18/2024 10:39 AM] |
| Filing 12 ECF FILER: ENTRY OF APPEARANCE from Ellen T. Noteware on behalf of Appellant(s) Drogueria Betances, Rochester Drug Co-Operative, Inc., Value Drug Company. [24-2202, 24-2203] (ETN) [Entered: 07/16/2024 04:08 PM] |
| Filing 11 ECF FILER: ENTRY OF APPEARANCE from Caitlin G. Coslett on behalf of Appellant(s) Drogueria Betances, Rochester Drug Co-Operative, Inc., Value Drug Company. [24-2202, 24-2203] (CGC) [Entered: 07/16/2024 03:58 PM] |
| Filing 10 ECF FILER: ENTRY OF APPEARANCE from David F. Sorensen on behalf of Appellant(s) Drogueria Betances, Rochester Drug Co-Operative, Inc., Value Drug Company. [24-2202, 24-2203] (DFS) [Entered: 07/16/2024 03:35 PM] |
| Filing 9 ECF FILER: ENTRY OF APPEARANCE from Kimberly Hennings on behalf of Appellant(s) Drogueria Betances, Rochester Drug Co-Operative, Inc. and Value Drug Company. [24-2203] (PSP) [Entered: 07/12/2024 01:35 PM] |
| Filing 8 ECF FILER: ENTRY OF APPEARANCE from Bruce E. Gerstein on behalf of Appellant(s) Drogueria Betances, Rochester Drug Co-Operative, Inc. and Value Drug Company. [24-2203] (PSP) [Entered: 07/12/2024 12:10 PM] |
| Filing 7 ECF FILER: ENTRY OF APPEARANCE from Matthew F. Gately, Esq. on behalf of Appellant(s) Plaintiffs Drogueria Betances, Professional Drug Company, Inc., Rochester Drug Co-Operative, Inc. Stephen L. LaFrance Holdings, Inc. and Value Drug Company. [24-2203] (MFG) [Entered: 07/09/2024 03:23 PM] |
| Filing 6 ENTRY OF APPEARANCE filed by Attorney Peter S. Pearlman, Esq. for Appellants Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc, Drogueria Betances, Professional Drug Co Inc and Value Drug Co in 24-2202.. [24-2202, 24-2203] (AMR) [Entered: 07/09/2024 02:24 PM] |
| Filing 5 ECF FILER: ENTRY OF APPEARANCE from Peter S. Pearlman, Esq. and Matthew F. Gately, Esq. on behalf of Appellant(s) Plaintiffs Drogueria Betances, Professional Drug Company, Inc., Rochester Drug Co-Operative, Inc. Stephen L. LaFrance Holdings, Inc. and Value Drug Company. [24-2203] (PSP) [Entered: 07/09/2024 10:31 AM] |
| Filing 4 CLERK ORDER: The above-captioned appeals are all consolidated for purposes of scheduling, the joint appendix, the appellees' response brief, and disposition. The appeals at Nos. 24-2202 and 24-2203 are further consolidated for all purposes. The appellants are encouraged to consult with one another regarding the contents of their briefs as the Court disfavors repetitive briefs. The appellants may file a consolidated brief or join in or adopt portions by reference. See Fed. R. App. P. 28(i). The parties are hereby directed to electronically file documents on the Court's docket as follows: Appellants: All case opening forms, motions, and briefs must be filed only in the appeal number assigned to the filer's notice of appeal. If a document is being filed jointly by multiple appellants, the document must be filed in the appeal numbers assigned to the filing appellants. Appellees: All case opening forms must be filed in all appeals in which the appellee intends to participate. All motions should be filed only in those cases for which the relief is being requested. Appellee's consolidated brief must be filed in all appeals to which the appellee is responding. The consolidated joint appendix must be filed in all appeal numbers. The parties are advised that case opening forms for later filed appeals must only be filed in the new appeals and not re-filed in earlier appeals in which the forms were previously filed. The parties are further advised that failure to file documents in the appropriate case may result in the issuance of a noncompliance order. If any party is unsure how to file a particular document, he or she should call the case manager prior to filing the document. [24-2184, 24-2185, 24-2189, 24-2194, 24-2202, 24-2203] (AMR) [Entered: 07/08/2024 05:03 PM] |
| Filing 3 NOTICE Pursuant to 3d Cir. L.A.R. 26.1, a document is timely filed if received by 5:00 p.m. ET on the last day for filing unless the Court sets a different time, the document has been submitted by an inmate pursuant to Fed. R. App. P. 25(a)(2)(A)(iii), or otherwise specified in L.A.R. 26.1 (AMR) [Entered: 07/08/2024 04:58 PM] |
| Filing 2 RECORD available on District Court CM/ECF. (AMR) [Entered: 07/08/2024 04:58 PM] |
| Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellants Drogueria Betances, Professional Drug Company Inc, Rochester Drug Cooperative Inc, Stephen L LaFrance Holdings Inc and Value Drug Co in District Court No. 3-12-cv-02389. (AMR) [Entered: 07/08/2024 04:55 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
